Building a Modern RTSM Platform Through Trust

When selecting a modern RTSM platform for clinical trials, trust and industry reputation are everything.

In a specialized field like Randomization and Trial Supply Management (RTSM), word of mouth spreads fast. Clinical operations teams consistently share their experiences, pointing their counterparts toward agile, reliable technology models that solve traditional clinical trial bottlenecks.

The Flywheel Effect of a Modern RTSM Platform

At Atreo, our growth has been fueled heavily by client referrals. Many organizations that initially weren't ready to transition have circled back after hearing firsthand success stories from their industry peers. Since opening our doors in 2022, we have rapidly scaled from our first handful of studies to over 100 clinical trials in less than four years.

This rapid adoption has created a powerful flywheel effect. As more study teams experience our unique approach, positive conversations happen more frequently across the industry, driving new clients to seek us out based entirely on our reputation for excellence.

Validation Through Repeat Business

Securing new clients is only half of the equation; true validation comes from keeping them. 100% of the customers we have delivered a system for have returned for repeat business. This perfect retention rate proves that our initial presentations aren't just empty promises, they are fully backed by superior technology and world-class client services.

As we look forward to expanding our baseline from 70 studies in 2026 to an anticipated 110 studies next year, we remain committed to partnering closely with our clients to ensure their clinical pipelines run flawlessly. If you are ready to see the difference explore our RTSM clinical trial solutions today.